LeadIQ logo
Learn more at LeadIQ.com

Insights

Global Expansion Opportunities Antengene has secured marketing authorizations for its lead asset in multiple Asia Pacific countries, indicating a potential for expansion into new international markets for sales growth.

Strategic Partnerships Partnerships with pharmaceutical companies like Jiangsu Hansoh Pharmaceutical Group present collaboration opportunities that could lead to increased sales channels and market penetration.

Clinical Trial Collaboration Engagement in clinical trials, such as the ongoing evaluation of new therapies, offers the chance to showcase efficacy in the market and attract new sales opportunities based on positive trial outcomes.

Innovative Product Development Continuous development of innovative therapies like the anti-cd24 monoclonal antibody and XPOVIO in combination therapies can drive interest among healthcare providers, potentially translating into increased sales demand.

Financial Backing for Growth Receiving substantial financing and upfront payments indicates financial stability, providing resources to invest in sales and marketing strategies for promoting existing products and expanding the product portfolio.

Similar companies to Antengene

Antengene Tech Stack

Antengene uses 8 technology products and services including WordPress Super Cache, WordPress, MySQL, and more. Explore Antengene's tech stack below.

  • WordPress Super Cache
    Caching
  • WordPress
    Content Management System
  • MySQL
    Database
  • Vue.js
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Animate.css
    UI Frameworks

Media & News

Antengene's Email Address Formats

Antengene uses at least 1 format(s):
Antengene Email FormatsExamplePercentage
First.Last@antengene.comJohn.Doe@antengene.com
49%
Last@antengene.comDoe@antengene.com
1%
First-Last@antengene.comJohn-Doe@antengene.com
1%
First.Last@antengene.comJohn.Doe@antengene.com
49%

Frequently Asked Questions

Where is Antengene's headquarters located?

Minus sign iconPlus sign icon
Antengene's main headquarters is located at Shanghai, Changning District 200000 CN. The company has employees across 4 continents, including AsiaNorth AmericaOceania.

What is Antengene's official website and social media links?

Minus sign iconPlus sign icon
Antengene's official website is antengene.com and has social profiles on LinkedIn.

What is Antengene's NAICS code?

Minus sign iconPlus sign icon
Antengene's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Antengene have currently?

Minus sign iconPlus sign icon
As of May 2024, Antengene has approximately 201 employees across 4 continents, including AsiaNorth AmericaOceania. Key team members include Chief Of Staff, Assistant Coo: A. G.Vice President Medical Affairs, Apac And Early Clinical Development: D. H.Head Of Medical Affairs, Apac: T. E.. Explore Antengene's employee directory with LeadIQ.

What industry does Antengene belong to?

Minus sign iconPlus sign icon
Antengene operates in the Pharmaceutical Manufacturing industry.

What technology does Antengene use?

Minus sign iconPlus sign icon
Antengene's tech stack includes WordPress Super CacheWordPressMySQLVue.jsSlickjQuerySwiperAnimate.css.

What is Antengene's email format?

Minus sign iconPlus sign icon
Antengene's email format typically follows the pattern of . Find more Antengene email formats with LeadIQ.

How much funding has Antengene raised to date?

Minus sign iconPlus sign icon
As of May 2024, Antengene has raised $97M in funding. The last funding round occurred on Jul 20, 2020 for $97M.

When was Antengene founded?

Minus sign iconPlus sign icon
Antengene was founded in 2017.
Antengene

Antengene

Pharmaceutical ManufacturingChangning District, China201-500 Employees

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of Treating Patients Beyond Borders. 

Since 2017, Antengene has built a pipeline of 9 oncology programs at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. We have successfully obtained marketing authorizations for selinexor, Antengene’s lead asset, in multiple Asia Pacific counties and regions including mainland China, Taiwan,China, South Korea, Singapore, and Australia.

Section iconCompany Overview

Headquarters
Shanghai, Changning District 200000 CN
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2017
Employees
201-500

Section iconFunding & Financials

  • $97M

    Antengene has raised a total of $97M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2020 in the amount of $97M.

Section iconFunding & Financials

  • $97M

    Antengene has raised a total of $97M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2020 in the amount of $97M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.